Available at Scholarships tab above
Posts belonging to Category Breaking News
This is the season of giving. Tuesday is National Day of Giving! Be a part of #GivingTuesday – DONATE to NJME/CFSA! NJ/MECFSA is a 501(c)(3) non-profit organization. DONATE at http://www.njcfsa.org/donate/ If you prefer there is also https://www.gofundme.com/ArpitaSheth-MyME (funds also go directly to the organization
The 2016 Scholarships have been posted. Click on the “Scholarships” tab above. The Medical Scholarship winner and runner-up essays are at that site.
Simple Way to Assess Orthostatic Intolerance
Dr. Nancy Klimas’ ME/CFS Gene Study at Nova Southeast University is still seeking patient and healthy volunteers. If you are interested, you can send a message to Helpdesk@njmecfsa.org and we will forward it to the study. More information can be found at https://sharkmedia.nova.edu/m…/ME+CFS+Genes+Study/1_06vh90p0 This is a chance for both patients and healthy volunteers to participate.
Read about the encouraging results at: http://www.meaction.net/2016/09/09/members-of-congress-urge-nih-director-francis-collins-to-strengthen-biomedical-research-into-myalgic-encephalomyelitis-chronic-fatigue-syndrome/
Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic First Product Approved for ME/CFS Indication Anywhere in the World. Ampligen Approved in Argentina – First in the World 2016-08-23
August is Membership Renewal Month Please support the work of NJME/CFSA. See information at the link below. 2016-08 Membership Renewal Request
Link includes the 10 poems. http://bit.ly/1UICjb5 i.e. http://www.meaction.net/…/…/meactions-poetry-contest-winners